Validations: CSV/CSA for Cloud/SaaS & Data Governance
KPI Sets for Report Quality KPI Sets for Report Quality In the highly regulated environment of pharmaceuticals, ensuring the integrity and quality of reports generated from computerized systems is essential. This need is underscored by regulations such as 21 CFR Part 11 and Annex 11, which govern electronic records and signatures. This article serves as a comprehensive, step-by-step tutorial for…
KPI Sets for Report Quality in Biopharmaceuticals: A Step-by-Step Guide Introduction to Key Performance Indicators (KPIs) in Biopharmaceutical Reporting In the biopharmaceutical industry, the integrity and accuracy of reporting are paramount. Key Performance Indicators (KPIs) serve as essential tools for monitoring and ensuring the quality of reports generated throughout the lifecycle of biopharmaceutical products. As organizations transition to cloud-based systems,…
Self-Service BI in GxP: Guardrails Self-Service BI in GxP: Guardrails The advent of self-service business intelligence (BI) in regulated environments presents a unique set of challenges and opportunities for pharmaceutical organizations. Compliance with Good Automated Manufacturing Practices (GxP) and relevant regulatory expectations is fundamental to ensuring that data used for decision-making in biopharmaceuticals is accurate, reliable, and defensible. This article…
Self-Service BI in GxP: Guardrails Self-Service BI in GxP: Guardrails Understanding GxP in the Context of Business Intelligence Good Practice (GxP) regulations refer to the quality guidelines and regulations set forth to ensure that products are safe, meet their intended use, and adhere to the required quality systems in the pharmaceutical industry. These include Good Manufacturing Practice (GMP), Good Laboratory…
Training for Report Owners Training for Report Owners: Ensuring Compliance in Report Validation Introduction to Report Validation in Biopharmaceuticals In the realm of biopharmaceutical products, maintaining compliance with regulatory standards is paramount. Report validation plays a critical role in ensuring the accuracy and integrity of data generated throughout the lifecycle of a product. As part of the broader Computer Software…
Training for Report Owners Training for Report Owners: Ensuring Compliance and Integrity in Data Reporting Introduction to Report Validation in the Pharmaceutical Sector The landscape of pharmaceutical development and manufacturing has witnessed a rapid transformation, particularly with the rise of biopharmaceuticals and biological products. Within this environment, **training for report owners** is crucial for maintaining compliance and integrity, particularly in…
Audit-Ready Report Catalogs Audit-Ready Report Catalogs Introduction to Audit-Ready Report Catalogs in Biopharmaceuticals In the world of biopharmaceuticals, compliance with regulatory standards is not just an option; it’s a necessity. Audit-ready report catalogs serve as a cornerstone for ensuring that your biological data, including methods for bioburden testing and bioanalytical processes, meet the stringent requirements set forth by agencies such…
Audit-Ready Report Catalogs Audit-Ready Report Catalogs: A Comprehensive Guide to Biological and Biopharmaceutical Validation Introduction to Audit-Ready Report Catalogs The current landscape of pharmaceutical validation demands robust audit-ready report catalogs, especially in the realms of biological, bioburden, and bioanalytical assessments. As organizations navigate through the rigorous compliance expectations set forth by the FDA, EMA, MHRA, and PIC/S, understanding the workflows…
Data Retention Rules: Legal, Regulatory, and Business Introduction to Data Retention in the Pharmaceutical Sector Data retention is a critical aspect of any organization engaged in pharmaceutical development and commercialization. Each regulatory body, including the FDA, EMA, MHRA, and PIC/S, emphasizes the importance of proper data management practices to ensure compliance, maintain quality assurances, and support regulatory submissions. As organizations…
Report Decommissioning: Sunsets with Evidence Report Decommissioning: Sunsets with Evidence Understanding the intricacies of report decommissioning in the pharmaceutical context is crucial for professionals engaged in biopharmaceuticals, bioburden control, and bioanalytical practices. This comprehensive guide details a systematic approach to ensuring compliance, integrating key principles of computer software assurance (CSA) and computer system validation (CSV) applicable in the environments governed…